Pune, India

Mahesh Bhadgale

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Liqmeds Worldwide Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahesh Bhadgale. Retrieved from https://idiyas.com/inventor/mahesh-bhadgale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahesh Bhadgale: Innovator in Oral Liquid Formulations

Introduction

Mahesh Bhadgale is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral liquid medications. His innovative approach has led to advancements that benefit patients suffering from acute musculoskeletal pain.

Latest Patents

Mahesh Bhadgale holds a patent for an oral liquid formulation of methocarbamol. This formulation is designed to be in the form of a suspension, providing an effective means of delivering the medication. The patent also includes a detailed process for preparing this oral liquid formulation, which is intended for the treatment of acute musculoskeletal pain. He has 1 patent to his name.

Career Highlights

Bhadgale is currently associated with Liqmeds Worldwide Limited, where he continues to work on innovative pharmaceutical solutions. His role at the company allows him to apply his expertise in formulation development and contribute to the advancement of healthcare.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Mahesh Bhadgale's work in developing oral liquid formulations showcases his commitment to improving patient care through innovation. His contributions to the pharmaceutical industry are noteworthy and reflect his dedication to advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…